GLI1-mediated regulation of side population is responsible for drug resistance in gastric cancer

Beiqin Yu, Dongsheng Gu, Xiaoli Zhang, Jianfang Li, Bingya Liu, Jingwu Xie

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Gastric cancer is the third leading cause of cancer-related mortality worldwide. Chemotherapy is frequently used for gastric cancer treatment. Most patients with advanced gastric cancer eventually succumb to the disease despite some patients responded initially to chemotherapy. Thus, identifying molecular mechanisms responsible for cancer relapse following chemotherapy will help design new ways to treat gastric cancer. In this study, we revealed that the residual cancer cells following treatment with chemotherapeutic reagent cisplatin have elevated expression of hedgehog target genes GLI1, GLI2 and PTCH1, suggestive of hedgehog signaling activation. We showed that GLI1 knockdown sensitized gastric cancer cells to CDDP whereas ectopic GLI1 expression decreased the sensitivity. Further analyses indicate elevated GLI1 expression is associated with an increase in tumor sphere formation, side population and cell surface markers for putative cancer stem cells. We have evidence to support that GLI1 is critical for maintenance of putative cancer stem cells through direct regulation of ABCG2. In fact, GLI1 protein was shown to be associated with the promoter fragment of ABCG2 through a Gli-binding consensus site in gastric cancer cells. Disruption of ABCG2 function, through ectopic expression of an ABCG2 dominant negative construct or a specific ABCG2 inhibitor, increased drug sensitivity of cancer cells both in culture and in mice. The relevance of our studies to gastric cancer patient care is reflected by our discovery that high ABCG2 expression was associated with poor survival in the gastric cancer patients who underwent chemotherapy. Taken together, we have identified a molecular mechanism by which gastric cancer cells gain chemotherapy resistance.

Original languageEnglish (US)
Pages (from-to)27412-27427
Number of pages16
JournalOncotarget
Volume8
Issue number16
DOIs
StatePublished - 2017

Fingerprint

Drug Resistance
Stomach Neoplasms
Population
Drug Therapy
Hedgehogs
Neoplastic Stem Cells
Neoplasms
Side-Population Cells
Residual Neoplasm
Cisplatin
Patient Care
Binding Sites
Maintenance
Recurrence
Survival
Mortality
Therapeutics
Pharmaceutical Preparations
Genes

Keywords

  • Chemoresistance
  • Cisplatin
  • Gastric cancer
  • GLI1
  • Hedgehog

ASJC Scopus subject areas

  • Oncology

Cite this

GLI1-mediated regulation of side population is responsible for drug resistance in gastric cancer. / Yu, Beiqin; Gu, Dongsheng; Zhang, Xiaoli; Li, Jianfang; Liu, Bingya; Xie, Jingwu.

In: Oncotarget, Vol. 8, No. 16, 2017, p. 27412-27427.

Research output: Contribution to journalArticle

Yu, Beiqin ; Gu, Dongsheng ; Zhang, Xiaoli ; Li, Jianfang ; Liu, Bingya ; Xie, Jingwu. / GLI1-mediated regulation of side population is responsible for drug resistance in gastric cancer. In: Oncotarget. 2017 ; Vol. 8, No. 16. pp. 27412-27427.
@article{507e1de0361f48809d375125885bd7c8,
title = "GLI1-mediated regulation of side population is responsible for drug resistance in gastric cancer",
abstract = "Gastric cancer is the third leading cause of cancer-related mortality worldwide. Chemotherapy is frequently used for gastric cancer treatment. Most patients with advanced gastric cancer eventually succumb to the disease despite some patients responded initially to chemotherapy. Thus, identifying molecular mechanisms responsible for cancer relapse following chemotherapy will help design new ways to treat gastric cancer. In this study, we revealed that the residual cancer cells following treatment with chemotherapeutic reagent cisplatin have elevated expression of hedgehog target genes GLI1, GLI2 and PTCH1, suggestive of hedgehog signaling activation. We showed that GLI1 knockdown sensitized gastric cancer cells to CDDP whereas ectopic GLI1 expression decreased the sensitivity. Further analyses indicate elevated GLI1 expression is associated with an increase in tumor sphere formation, side population and cell surface markers for putative cancer stem cells. We have evidence to support that GLI1 is critical for maintenance of putative cancer stem cells through direct regulation of ABCG2. In fact, GLI1 protein was shown to be associated with the promoter fragment of ABCG2 through a Gli-binding consensus site in gastric cancer cells. Disruption of ABCG2 function, through ectopic expression of an ABCG2 dominant negative construct or a specific ABCG2 inhibitor, increased drug sensitivity of cancer cells both in culture and in mice. The relevance of our studies to gastric cancer patient care is reflected by our discovery that high ABCG2 expression was associated with poor survival in the gastric cancer patients who underwent chemotherapy. Taken together, we have identified a molecular mechanism by which gastric cancer cells gain chemotherapy resistance.",
keywords = "Chemoresistance, Cisplatin, Gastric cancer, GLI1, Hedgehog",
author = "Beiqin Yu and Dongsheng Gu and Xiaoli Zhang and Jianfang Li and Bingya Liu and Jingwu Xie",
year = "2017",
doi = "10.18632/oncotarget.16174",
language = "English (US)",
volume = "8",
pages = "27412--27427",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "16",

}

TY - JOUR

T1 - GLI1-mediated regulation of side population is responsible for drug resistance in gastric cancer

AU - Yu, Beiqin

AU - Gu, Dongsheng

AU - Zhang, Xiaoli

AU - Li, Jianfang

AU - Liu, Bingya

AU - Xie, Jingwu

PY - 2017

Y1 - 2017

N2 - Gastric cancer is the third leading cause of cancer-related mortality worldwide. Chemotherapy is frequently used for gastric cancer treatment. Most patients with advanced gastric cancer eventually succumb to the disease despite some patients responded initially to chemotherapy. Thus, identifying molecular mechanisms responsible for cancer relapse following chemotherapy will help design new ways to treat gastric cancer. In this study, we revealed that the residual cancer cells following treatment with chemotherapeutic reagent cisplatin have elevated expression of hedgehog target genes GLI1, GLI2 and PTCH1, suggestive of hedgehog signaling activation. We showed that GLI1 knockdown sensitized gastric cancer cells to CDDP whereas ectopic GLI1 expression decreased the sensitivity. Further analyses indicate elevated GLI1 expression is associated with an increase in tumor sphere formation, side population and cell surface markers for putative cancer stem cells. We have evidence to support that GLI1 is critical for maintenance of putative cancer stem cells through direct regulation of ABCG2. In fact, GLI1 protein was shown to be associated with the promoter fragment of ABCG2 through a Gli-binding consensus site in gastric cancer cells. Disruption of ABCG2 function, through ectopic expression of an ABCG2 dominant negative construct or a specific ABCG2 inhibitor, increased drug sensitivity of cancer cells both in culture and in mice. The relevance of our studies to gastric cancer patient care is reflected by our discovery that high ABCG2 expression was associated with poor survival in the gastric cancer patients who underwent chemotherapy. Taken together, we have identified a molecular mechanism by which gastric cancer cells gain chemotherapy resistance.

AB - Gastric cancer is the third leading cause of cancer-related mortality worldwide. Chemotherapy is frequently used for gastric cancer treatment. Most patients with advanced gastric cancer eventually succumb to the disease despite some patients responded initially to chemotherapy. Thus, identifying molecular mechanisms responsible for cancer relapse following chemotherapy will help design new ways to treat gastric cancer. In this study, we revealed that the residual cancer cells following treatment with chemotherapeutic reagent cisplatin have elevated expression of hedgehog target genes GLI1, GLI2 and PTCH1, suggestive of hedgehog signaling activation. We showed that GLI1 knockdown sensitized gastric cancer cells to CDDP whereas ectopic GLI1 expression decreased the sensitivity. Further analyses indicate elevated GLI1 expression is associated with an increase in tumor sphere formation, side population and cell surface markers for putative cancer stem cells. We have evidence to support that GLI1 is critical for maintenance of putative cancer stem cells through direct regulation of ABCG2. In fact, GLI1 protein was shown to be associated with the promoter fragment of ABCG2 through a Gli-binding consensus site in gastric cancer cells. Disruption of ABCG2 function, through ectopic expression of an ABCG2 dominant negative construct or a specific ABCG2 inhibitor, increased drug sensitivity of cancer cells both in culture and in mice. The relevance of our studies to gastric cancer patient care is reflected by our discovery that high ABCG2 expression was associated with poor survival in the gastric cancer patients who underwent chemotherapy. Taken together, we have identified a molecular mechanism by which gastric cancer cells gain chemotherapy resistance.

KW - Chemoresistance

KW - Cisplatin

KW - Gastric cancer

KW - GLI1

KW - Hedgehog

UR - http://www.scopus.com/inward/record.url?scp=85017524117&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85017524117&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.16174

DO - 10.18632/oncotarget.16174

M3 - Article

AN - SCOPUS:85017524117

VL - 8

SP - 27412

EP - 27427

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 16

ER -